Moodie Z, Dintwe O, Sawant S, Grove D, et al. Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk. J Infect Dis 2022 Jun 27. pii: 6618597. doi: 10.1093.
PMID: 35758878